Patents by Inventor Lino X. Rodrigues, JR.

Lino X. Rodrigues, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Treating HCV
    Publication number: 20180177778
    Abstract: The present invention features interferon-free therapies for treating Hepatitis C Virus (HCV) genotypes 1b, 2, 3 or 4. In one aspect, the therapies comprises administering Compound 1 (Paritaprevir), Ritonavir, and Compound 2 (Ombitasvir) to a subject infected with HCV genotype 1b or 4, wherein the therapies do not include the administration of any interferon, and the therapies last from 8 to 12 weeks. Preferably, the therapies do not include the administration of any ribavirin.
    Type: Application
    Filed: June 28, 2016
    Publication date: June 28, 2018
    Applicant: AbbVie Inc.
    Inventors: Walid M. Awni, Tolga Baykal, Barry M. Bernstein, Scott c. Brun, Daniel E. Cohen, Emily O. Dumas, Sandeep Dutta, Amit Khatri, Cheri E. Klein, Rajeev M. Menon, Sven Mensing, Thomas J. Podsadecki, Lino X Rodrigues Jr., Regis A. Vilchez
  • Methods for Treating HCV
    Publication number: 20150011481
    Abstract: The present invention features interferon-free therapies for treating HCV genotype 1b, 2, 3 or 4. In one aspect, the therapies comprise administering Compound 1, ritonavir, and Compound 2 to a subject infected with HCV genotype 1b or 4, wherein the therapies do not include administration of any interferon, and the therapies last for 12 weeks. Preferably, the therapies do not include administration of any ribavirin.
    Type: Application
    Filed: July 1, 2014
    Publication date: January 8, 2015
    Inventors: Regis A. Vilchez, Lino X. Rodrigues, JR., Barry M. Bernstein, Thomas J. Podsadecki, Scott C. Brun, Daniel E. Cohen, Rajeev M. Menon, Amit Khatri, Sven Mensing, Sandeep Dutta, Walid M. Awni, Emily O. Dumas, Cheri E. Klein, Tolga Baykal